HEALTH TOPICS 
New drug offers warfarin alternative for atrial fibrillation
An immediate switch is right for some people, but not necessary for all.
A newly approved alternative to warfarin, a drug called dabigatran (sold under the brand name Pradaxa), fights stroke better than warfarin, with less bleeding into the brain, among people with atrial fibrillation. It could also make life a little bit easier for them.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise